Iso, Kazuki
,
Nagashima, Koichi
Arai, Masaru
Watanabe, Ryuta
Yokoyama, Katsuaki
Matsumoto, Naoya
Otsuka, Takayuki
Suzuki, Shinya
Hirata, Akio
Murakami, Masato
Takami, Mitsuru
Kimura, Masaomi
Fukaya, Hidehira
Nakahara, Shiro
Kato, Takeshi
Hayashi, Hiroshi
Iwasaki, Yu-ki
Shimizu, Wataru
Nakajima, Ikutaro
Harada, Tomoo
Koyama, Junjiroh
Okumura, Ken
Tokuda, Michifumi
Yamane, Teiichi
Tanimoto, Kojiro
Momiyama, Yukihiko
Nonoguchi, Noriko
Soejima, Kyoko
Ejima, Koichiro
Hagiwara, Nobuhisa
Harada, Masahide
Sonoda, Kazumasa
Inoue, Masaru
Kumagai, Koji
Hayashi, Hidemori
Yazaki, Yoshinao
Satomi, Kazuhiro
Watari, Yuji
Okumura, Yasuo http://orcid.org/0000-0002-2960-4241
Article History
Received: 10 June 2020
Accepted: 23 October 2020
First Online: 24 November 2020
Compliance with ethical standard
:
: The following authors have potential conflicts of interest. Nihon University Itabashi Hospital, Clinical Research Judging Committee (No. RK-161213-06 and RK-130111-2). YO has received research funding from Bayer Healthcare, Daiichi-Sankyo, Bristol-Meyers Squibb, Nippon Boehringer Ingelheim, Pfizer Japan, TORAY, and Boston Scientific Japan and has accepted remuneration from Bayer Healthcare, Daiichi-Sankyo, and Bristol-Meyers Squibb. NM has received research funding from Daiichi-Sankyo. SS received research funding from Daiichi-Sankyo and Mitsubishi-Tanabe. AH has received accepted remuneration from Nippon Boehringer Ingelheim, Bayer Healthcare, Bristol-Myers Squibb, Daiichi-Sankyo. MK has received accepted remuneration from Johnson & Johnson K.K., Medtronic Japan, Bayer Healthcare. HF has received lecture fees from Nippon Boehringer Ingelheim and Daiichi-Sankyo. SN has received lecture fees from Bayer Healthcare, Daiichi-Sankyo, Bristol-Meyers Squibb, Pfizer Japan, and Nippon Boehringer Ingelheim. TK has received research grant from Daiichi-Sankyo, and lecture fees from Bristol-Myers Squibb, Daiichi-Sankyo and Nippon Boehringer Ingelheim, and honoraria for writing promotional material for Bristol-Myers Squibb. WS has received research funding from Bristol-Myers Squibb, Daiichi-Sankyo, and Nippon Boehringer Ingelheim, patent royalties/licensing fees from Daiichi-Sankyo, Pfizer Japan, Bristol-Myers Squibb, Bayer Healthcare, and Nippon Boehringer Ingelheim, and he is the Circulation Journal Editorial Team. TH serves as a consultant to Medtronic Japan and has received lecture fees from Daiichi-Sankyo. IN has received a scholarship from the Japanese Heart Rhythm Society and received speaking honoraria from Medtronic Japan. K.O. has received remuneration from Nippon Boehringer Ingelheim, Daiichi-Sankyo, Johnson & Johnson, and Medtronic Japan. MT serves as a consultant to Medtronic Japan. TY has received lecture fees from Daiichi-Sankyo and Abbott Medical Japan. KT has received lecture fees from Daiichi-Sankyo, Nippon Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer Japan, Bayer Healthcare. KS has received research funding from Daiichi-Sankyo and Nippon Boehringer Ingelheim, and accepted remuneration from Medtronic Japan, Jonson & Jonson, and Abbott Medical Japan. NH has received accepted remuneration from Nippon Boehringer Ingelheim, Bristol-Myers Squibb, Bayer Healthcare, and research funding from Bayer Healthcare, Nippon Boehringer Ingelheim, Daiichi-Sankyo, and he is the Circulation Journal Editorial Team. MH has lecture fee from Nippon Boehringer Ingelheim and Bristol-Myers Squibb. KS and YA have received research funding from BIOTRONIK Japan. Other authors have no conflict of interest.
: Nihon University Itabashi Hospital, Clinical Research Judging Committee (No. RK-161213-06 and RK-130111-2).